Genotoxic effects of ethylene oxide, propylene oxide and epichlorohydrin in humans: Update review (1990-2001)

Mutation Research - Reviews in Mutation Research

Volumn 512, Issue 2-3, 2002, Pages 173-194

  Kolman, Ada ^a   Chovanec, Miroslav ^b   Osterman Golkar, Siv ^a  

^a STOCKHOLM UNIVERSITY   (Sweden)

^b CANCER RESEARCH INSTITUTE   (Slovakia)

Author keywords

Carcinogenic effects; Cytogenetic effects; DNA and hemoglobin adducts; Epichlorohydrin; Epidemiological studies; Ethylene oxide; Propylene oxide

Indexed keywords

BIOLOGICAL MARKER; EPICHLOROHYDRIN; ETHYLENE OXIDE; PROPYLENE OXIDE;

ACUTE GRANULOCYTIC LEUKEMIA; CANCER CELL CULTURE; CANCER MORTALITY; CANCER RISK; CARCINOGENIC ACTIVITY; CARCINOGENICITY; CELL INTERACTION; CHRONIC LYMPHATIC LEUKEMIA; CYTOGENETICS; DATA BASE; DNA ADDUCT; DNA POLYMORPHISM; EPIDEMIOLOGICAL DATA; GENETIC POLYMORPHISM; GENOTOXICITY; HEMOGLOBIN ANALYSIS; HUMAN; MAMMAL CELL; NONHODGKIN LYMPHOMA; NONHUMAN; POLLUTANT; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVIEW; RISK ASSESSMENT; SMOKING; STOMACH CANCER;

MAMMALIA;

EID: 0036897994     PISSN: 13835742     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1383-5742(02)00067-4     Document Type: Review

References (129)

1. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, vol. 60, IARC, Lyon, 1994, pp. 73-213.
2. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, vol. 71, IARC, Lyon, 1999, pp. 603-628.
3. National Institute for Occupational Safety and Health, National Occupational Exposure Survey: Sampling Methodology, NIOSH, Cincinnati, 1990, pp. 89-102.
4. Ehrenberg L., Osterman-Golkar S., Segerbäck D., Svensson K., Calleman C.J. Evaluation of genetic risks of alkylating agents. III. Alkylation of hemoglobin after metabolic conversion of ethene to ethylene oxide in vivo. Mutat. Res. 45:1977;175-184.
5. Törnqvist M., Almberg J., Nilsson S., Osterman-Golkar S. Ethylene oxide doses in ethene exposed fruit store workers. Scand. J. Work Environ. Health. 15:1989;436-438.
6. Filser J.G., Denk B., Törnqvist M., Kessler W., Ehrenberg L. Pharmacokinetics of ethylene in man body burden with ethylene oxide and hydroxyethylation of hemoglobin due to endogenous and environmental ethylene. Arch. Toxicol. 66:1992;157-163.
7. Törnqvist M., Gustafsson B., Kautiainen A., Harms-Ringdahl M., Granath F., Ehrenberg L. Unsaturated lipids and intestinal bacteria as sources of endogenous production of ethene and ethylene oxide. Carcinogenesis. 10:1989;39-41.
8. Bolt H.M. The carcinogenic risk of ethene (ethylene). Toxicol. Pathol. 26:1998;454-456.
9. L. Ehrenberg, T. Hällström, Haematologic studies on persons occupationally exposed to ethylene oxide, in: Radiosterilization of Medical Products, International Atomic Energy Agency SM 92/96, IAEA, Vienna, 1967, pp. 327-334.
10. Ehrenberg L., Hussain S. Genetic toxicity of some important epoxides. Mutat. Res. 86:1981;1-113.
11. Kolman A., Näslund M., Calleman C.J. Genotoxic effects of ethylene oxide and their relevance to human cancer. Carcinogenesis. 7:1986;1245-1250.
12. Dellarco V.L., Generoso W.M., Sega G.A., Fowle J.R. Jr., Jacobson-Kram D. Review of the mutagenicity of ethylene oxide. Environ. Mol. Mutagen. 16:1990;85-103.
13. Nilsson R., Molholt B., Sargent E.V. Quantitative assessment of a human carcinogenic potency for propylene oxide. Regul. Toxicol. Pharmacol. 14:1991;229-244.
14. Giri A.K. Genetic toxicology of propylene oxide and trichloropropylene oxide - a review. Mutat. Res. 277:1992;1-9.
15. Shore R.E., Gardner M.J., Pannett B. Ethylene oxide: an assessment of the epidemiological evidence on carcinogenicity. Br. J. Ind. Med. 50:1993;971-997.
16. Sinsheimer J.E., Chen R., Das S.K., Hooberman B.H., Osorio S., You Z. The genotoxicity of enentiomeric aliphatic epoxides. Mutat. Res. 298:1993;197-206.
17. Natarajan A.T., Preston R.J., Dellarco V., Ehrenberg L., Generoso W., Lewis S., Tates A.D. Ethylene oxide: evaluation of genotoxicity data and an exploratory assessment of genetic risk. Mutat. Res. 303:1995;55-70.
18. Ríos-Blanco M.N., Plná K., Faller T., Kessler W., Håkansson K., Kreutzer P.E., Ranasinghe A., Filser J.G., Segerbäck D., Swenberg J.A. Propylene oxide: its relationship to mutagenesis. Mutat. Res. 380:1997;179-197.
19. Preston R.J. Cytogenetic effects of ethylene oxide, with an emphasis on population monitoring. Crit. Rev. Toxicol. 29:1999;263-282.
20. Teta M.J., Sielken R.L. Jr., Valdez-Flores C. Ethylene oxide cancer risk assessment based on epidemiological data: application of revised regulatory guidelines. Risk Anal. 19:1999;1135-1155.
21. Their R., Bolt H.M. Carcinogenicity and genotoxicity of ethylene oxide: new aspects and recent advances. Crit. Rev. Toxicol. 30:2000;595-608.
22. Högstedt C., Malmqvist N., Wadman B. Leukemia in workers exposed to ethylene oxide. J. Am. Med. Assoc. 241:1979;1132-1133.
23. Högstedt C., Rohlén O., Berndtsson B.S., Axelson O., Ehrenberg L. A cohort study of mortality and cancer incidence in ethylene oxide production workers. Br. J. Ind. Med. 36:1979;276-280.
24. Högstedt C., Aringer L., Gustavsson A. Epidemiologic support for ethylene oxide as a cancer-causing agent. J. Am. Med. Assoc. 255:1986;1575-1578.
25. L.C. Hogstedt, in: H. Bartsch, K. Hemminki, I.K. O'Neill (Eds.), Epidemiological Studies on Ethylene Oxide and Cancer: An Updating, vol. 89, IARC, Lyon, 1988, pp. 265-270.
26. Bisanti L., Maggini M., Raschetti R., Alegiani S.S., Ippolito F.M., Caffari B., Segnan N., Ponti A. Cancer mortality in ethylene oxide workers. Br. J. Ind. Med. 50:1993;317-324.
27. Kiesselbach N., Ulm K., Lange H.-J., Korallus U. A multicentre mortality study of workers exposed to ethylene oxide. Br. J. Ind. Med. 47:1990;182-188.
28. Greenberg H.L., Ott M.G., Shore R.E. Men assigned to ethylene oxide production or other ethylene oxide related chemical manufacturing: a mortality study. Br. J. Ind. Med. 47:1990;221-230.
29. Hagmar L., Welinder H., Lindén K., Attewell R., Osterman-Golkar S., Törnqvist M. An epidemiological study of cancer risk among workers exposed to ethylene oxide using hemoglobin adducts to validate environmental exposure assessments. Int. Arch. Occup. Environ. Health. 63:1991;271-277.
30. Hagmar L., Mikoczy Z., Welinder H. Cancer incidence in Swedish sterilant workers exposed to ethylene oxide. Occup. Environ. Med. 52:1995;154-156.
31. Steenland K., Stainer L., Greife A., Halperin W., Hayes R., Hornung R., Nowlin S. Mortality among workers exposed to ethylene oxide. N. Engl. J. Med. 324:1991;1402-1407.
32. Wong O., Trent L. An epidemiological study of workers potentially exposed to ethylene oxide. Br. J. Ind. Med. 50:1993;308-316.
33. Teta M.J., Benson L.O., Vitale J.N. Mortality study of ethylene oxide workers in chemical manufacturing: a 10-year update. Br. J. Ind. Med. 50:1993;704-709.
34. Olsen G.W., Lacy S.E., Bodner K.M., Chau M., Arceneaux T.G., Cartmill J.B., Ramlow J.M., Boswell J.M. Mortality from pancreatic and lymphopoietic cancer among workers in ethylene and propylene chlorohydrin production. Occup. Environ. Med. 54:1997;592-598.
35. Norman S.A., Berlin J.A., Soper K.A., Middendorf B.F., Stolley P.D. Cancer incidence in a group of workers potentially exposed to ethylene oxide. Int. J. Epidemiol. 24:1995;276-284.
36. Morgan R.W., Claxton K., Divine B., Kaplan S., Harris V. Mortality among ethylene oxide workers. J. Occup. Med. 23:1981;767-770.
37. A.M. Thiess, R. Frentzel-Beyme, R. Link, W. Stocker, Mortality study on employees exposed to alkylene oxides (ethylene oxide/propylene oxide) and their derivatives, in: Prevention of Occupational Cancer, Occupational Safety and Health Series, vol. 46, International Labour Office, Geneva, 1981, pp. 249-259.
38. Gardner M.J., Coggon D., Pannet B., Harris E.C. Workers exposed to ethylene oxide: a follow-up study. Br. J. Ind. Med. 46:1989;860-865.
39. Enterline P.E., Henderson V., Marsh G. Mortality of workers potentially exposed to epichlorohydrin. Br. J. Ind. Med. 47:1990;269-276.
40. Tsai S.P., Cowles S.R., Tackett D.L., Barclay M.T., Ross C.E. Morbidity prevalence study of workers with potential exposure to epichlorohydrin. Br. J. Ind. Med. 47:1990;392-399.
41. Tsai S.P., Gilstrap E.L., Ross C.E. Mortality study of employees with potential exposure to epichlorohydrin: a 10-year update. Occup. Environ. Med. 53:1996;299-304.
42. Olsen G.W., Lacy S.E., Chamberlin S.R., Albert D.L., Arceneaux T.G., Bullard L.F., Stafford B.A., Boswell J.M. Retrospective cohort mortality study of workers with potential exposure to epichlorohydrin and allyl chloride. Am. J. Ind. Med. 25:1994;205-218.
43. Barbone F., Delzell E., Austin H., Cole P. A case-control study of lung cancer at a dye and resin manufacturing plant. Am. J. Ind. Med. 22:1992;835-849.
44. Barbone F., Delzell E., Austin H., Cole P. Exposure to epichlorohydrin and central nervous system neoplasms at a resin and dye manufacturing plant. Arch. Environ. Health. 49:1994;355-359.
45. Delzell E., Macaluso M., Cole P. A follow-up study of workers at a dye and resin manufacturing plant. J. Occup. Med. 31:1989;273-278.
46. Dunkelberg H. Carcinogenicity of ethylene oxide and 1,2-propylene oxide upon intragastric administration to rats. Br. J. Cancer. 46:1982;924-933.
47. Lynch D.W., Lewis T.R., Moorman W.J., Burg J.R., Groth D.H., Khan A., Ackerman L.J., Cockrell B.Y. Carcinogenic and toxicologic effects of inhaled ethylene oxide and propylene oxide in F344 rats. Toxicol. Appl. Pharmacol. 76:1984;69-84.
48. IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man, vol. 20, IARC, Lyon, 1979.
49. Wester P.W., van der Heijden C.A., Bisschop A., van Esch G.J. Carcinogenicity study with epichlorohydrin (CEP) by gavage in rats. Toxicology. 36:1985;325-339.
50. Mayer J., Warburton D., Jeffrey A.M., Pero R., Walles S., Andrews L., Toor M., Latriano L., Wazneh L., Tang D., Tsai W.-Y., Kuroda M., Perera F. Biologic markers in ethylene oxide-exposed workers and controls. Mutat. Res. 248:1991;163-176.
51. Tates A.D., Grummit T., Törnqvist M., Farmer P.B., van Dam F.J., van Mossel H., Schoemaker H.M., Osterman-Golkar S., Uebel C., Tang Y.S., Zwinderman A.H., Natarajan A.T., Ehrenberg L. Biological and chemical monitoring of occupational exposure to ethylene oxide. Mutat. Res. 250:1991;483-497.
52. Schulte P.A., Boeniger M., Walker J.T., Schober S.E., Pereira M.A., Gulati D.K., Wojciechowski J.P., Garza A., Froelich R., Strauss G., Halperin W.E., Herrick R., Griffith J. Biologic markers in hospital workers exposed to low levels of ethylene oxide. Mutat. Res. 278:1992;237-251.
53. Lerda D., Rizzi R. Cytogenetic study of persons occupationally exposed to ethylene oxide. Mutat. Res. 281:1992;31-37.
54. Major J., Jakob M.J., Tompa A. Genotoxicological investigation of hospital nurses occupationally exposed to ethylene oxide. 1. Chromosome aberrations, sister chromatid exchanges, cell cycle kinetics, and UV-induced DNA synthesis in peripheral blood lymphocytes. Environ. Mol. Mutagen. 27:1996;84-92.
55. Popp W., Vahrenholz C., Przygoda H., Brauksiepe A., Goch S., Muller G., Schell C., Norpoth K. DNA-protein cross-links and sister chromatid exchange frequencies in lymphocytes and hydroxyethyl mercapturic acid in urine of ethylene oxide-exposed hospital workers. Int. Arch. Occup. Environ. Health. 66:1994;325-332.
56. Tomkins D.J., Haines T., Lawrence M., Rosa N. A study of sister chromatid exchange and somatic cell mutation in hospital workers exposed to ethylene oxide. Environ. Health Perspect. Suppl. 101:1993;159-164.
57. Tates A.D., Boogaard P.J., Darroudi F., Natarajan A.T., Caubo M.F., van Sittert N.J. Biological effect monitoring in industrial workers following incidental exposure to high concentrations of ethylene oxide. Mutat. Res. 329:1995;63-77.
58. Fuchs J., Wullenweber U., Hengstler J.G., Bienfait H.G., Hiltl G., Oesch F. Genotoxic risk for humans due to workplace exposure to ethylene oxide: remarkable individual differences in susceptibility. Arch. Toxicol. 68:1994;343-348.
59. Oesch F., Hengstler J.G., Fuchs J. Cigarette smoking protects mononuclear blood cells of carcinogen exposed workers from additional work exposure-induced DNA single-strand breaks. Mutat. Res. 321:1994;175-185.
60. Hogstedt B., Bergmark E., Törnqvist M., Osterman-Golkar S. Chromosomal aberrations and micronuclei in lymphocytes in relation to alkylation of hemoglobin in workers exposed to ethylene oxide and propylene oxide. Hereditas. 113:1990;133-138.
61. Ribeiro L.R., Salvadori D.M.F., Rios A.C.C., Costa S.L., Tates A.D., Törnqvist M., Natarajan A.T. Biological monitoring of workers occupationally exposed to ethylene oxide. Mutat. Res. 313:1994;81-87.
62. Sarto F., Tomanin R., Giacomelli L., Iannini G., Cupiraggi A.R. The micronucleus assay in human exfoliated cells of the nose and mouth: application to occupational exposures to chromic acid and ethylene oxide. Mutat. Res. 244:1990;345-351.
63. Sarto F., Törnqvist M., Tomanin R., Bartolucci G.B., Osterman-Golkar S., Ehrenberg L. Studies of biological and chemical monitoring of low-level exposure to ethylene oxide. Scand. J. Environ. Health. 17:1991;60-64.
64. Czene K., Osterman-Golkar S., Yun X., Li G., Zhao F., Licea Pérez H., Natarajan A.T., Segerbäck D. Analysis of DNA and hemoglobin adducts and sister chromatid exchanges in a human population occupationally exposed to propylene oxide - a pilot study. Cancer Epidemiol. Biomarkers Prev. 11:2002;315-318.
65. Hindsø Landin H., Grummt T., Laurent C., Tates A. Monitoring of occupational exposure to epichlorohydrin by genetic effects and hemoglobin adducts. Mutat. Res. 381:1997;217-226.
66. Cheng T.-J., Hwang S.-J., Kuo H.W., Luo J.-C., Chang M.J.W. Exposure to epichlorohydrin and dimethylformamide. Arch. Toxicol. 73:1999;282-287.
67. Albertini R.J. Somatic gene mutations in vivo as indicated by the 6-thioguanine-resistant T-lymphocytes in human blood. Mutat. Res. 150:1985;411-422.
68. Ember I., Kiss I., Málovics I. Oncogene and tumour suppressor gene expression changes in persons exposed to ethylene oxide. Eur. J. Cancer Prev. 7:1998;167-168.
69. Ember I., Kiss I., Gombkötö G., Müller E., Szeremi M. Oncogene and suppressor gene expression as a biomarker for ethylene oxide exposure. Cancer Detect. Prev. 22:1998;241-245.
70. Singh U.S., Decker-Samuelian K., Solomon J.J. Reaction of epichlorohydrin with 2′-deoxynucleosides: characterization of adducts. Chem. Biol. Interact. 99:1996;109-128.
71. Young T.L., Habraken Y., Ludlum D.B., Santella R.M. Development of monoclonal antibodies recognizing 7-(2-hydroxyethyl)guanine and imidazole ring-opened 7-(2-hydroxyethyl)guanine. Carcinogenesis. 11:1990;1685-1689.
72. 6-positions. Chem. Res. Toxicol. 3:1995;389-395.
73. 6-substituted adenine and 3-substituted cytosine/uracil: formation and persistence in vitro and in vivo Carcinogenesis. 20:1999;2025-2032.
74. Solomon J.J., Mukai F., Fedyk J., Segal A. Reactions of propylene oxide with 2′-deoxynucleosides and in vitro with calf thymus DNA. Chem. Biol. Interact. 67:1988;275-294.
75. Solomon J.J., Segal A. DNA adducts of propylene oxide and acrylonitrile epoxide: hydrolytic deamination of 3-alkyl-dCyd to 3-alkyl-dUrd. Environ. Health Perspect. 81:1989;19-22.
76. 32P -post-labelling of 7-(3-chloro-2-hydroxypropyl)guanine in white blood cells of workers occupationally exposed to epichlorohydrin Carcinogenesis. 21:2000;275-280.
77. Koskinen M., Plná K. Specific DNA adducts induced by some mono-substituted epoxides in vitro and in vivo. Chem. Biol. Interact. 129:2000;209-229.
78. Segerbäck D. Reaction products in hemoglobin and DNA after in vitro treatment with ethylene oxide and N-(2-hydroxyethyl)-N-nitrosourea. Carcinogenesis. 11:1990;307-312.
79. Li F., Segal A., Solomon J.J. In vitro reaction of ethylene oxide with DNA and characterization of DNA adducts. Chem. Biol. Interact. 83:1992;35-54.
80. Walker V.E., Fennell T.R., Upton P.B., Skopek T.R., Prevost V., Shuker D.E.G., Swenberg J.A. Molecular dosimetry of ethylene oxide: formation and persistence of 7-(2-hydroxyethyl)guanine in DNA following repeated exposures of rats and mice. Cancer Res. 52:1992;4328-4334.
81. Wu K.-Y., Scheller N., Ranasinghe A., Yen T.-Y., Sangaiah R., Giese R., Swenberg J.A. A gas chromatography/electron capture/negative chemical ionization high-resolution mass spectrometry method for analysis of endogenous and exogenous N7-(2-hydroxyethyl)guanine in rodents and its potential for human biological monitoring. Chem. Res. Toxicol. 12:1999;722-729.
82. 32P -post-labelling Chem. Biol. Interact. 115:1998;229-246.
83. Hindsø Landin H., Segerbäck D., Damberg C., Osterman-Golkar S. Adducts with haemoglobin and with DNA in epichlorohydrin-exposed rats. Chem. Biol. Interact. 117:1999;49-64.
84. Zhao C., Tyndyk M., Eide I., Hemminki K. Endogenous and background DNA adducts by methylating and 2-hydroxyethylating agents. Mutat. Res. 424:1999;117-125.
85. Zhao C., Hemminki K. The in vivo levels of DNA alkylation products in human lymphocytes are not age dependent: an assay of 7-methyl- and 7-(2-hydroxyethyl)guanine DNA adducts. Carcinogenesis. 23:2002;307-310.
86. van Delft J.H., van Winden M.J., Luiten-Schuite A., Ribeiro L.R., Baan R.A. Comparison of various immunochemical assays for the detection of ethylene oxide-DNA adducts with monoclonal antibodies against imidazole ring-opened N7-(2-hydroxyethyl)guanosine: application in a biological monitoring study. Carcinogenesis. 15:1994;1867-1873.
87. Fennell T.R., Sumner S.C.J., Walker V.E. A model for the formation and removal of hemoglobin adducts. Cancer Epidemiol. Biomarkers Prev. 1:1992;213-219.
88. Granath F., Ehrenberg L., Törnqvist M. Degree of alkylation of macromolecules in vivo from variable exposure. Mutat. Res. 284:1992;297-306.
89. H. Hindsø Landin, Biomonitoring of Epichlorohydrin and Some Related Compounds, Thesis, Stockholm University, 2000.
90. Boogaard P.J., Rocchi P.S.J., van Sittert N.J. Biomonitoring of exposure to ethylene oxide and propylene oxide by determination of hemoglobin adducts: correlations between airborne exposure and adduct levels. Int. Arch. Occup. Environ. Health. 72:1999;142-150.
91. Angerer J., Bader M., Krämer A. Ambient and biochemical effect monitoring of workers exposed to ethylene oxide. Int. Arch. Occup. Environ. Health. 71:1998;14-18.
92. Ehrenberg L., Törnqvist M. The research background for risk assessment of ethylene oxide: aspects of dose. Mutat. Res. 330:1995;41-54.
93. Bader M., Lewalter J., Angerer J. Analysis of N-alkylated amino acids in human hemoglobin: evidence for elevated N-methylvaline levels in smokers. Int. Arch. Occup. Environ. Health. 67:1995;237-242.
94. Bergmark E. Hemoglobin adducts of acrylamide and acrylonitrile in laboratory workers. Chem. Res. Toxicol. 10:1997;78-84.
95. Bono R.B., Vincenti M., Meineri V., Pignata C., Saglia U., Giachino O., Scursatone E. Formation of N-(2-hydroxyethyl)valine due to exposure to ethylene oxide via tobacco smoke: a risk factor for onset of cancer. Environ. Res. Sect. A. 81:1999;62-71.
96. M. Törnqvist, L. Ehrenberg, Approaches to risk assessment of automotive engine exhausts, In: H. Vainio, M. Sorsa, A.J. McMichael (Eds.), Complex Mixtures and Cancer Risk, IARC, Lyon, 1990, pp. 277-287.
97. Tavares R., Ramos P., Palminha J., Bispo M.A., Paz I., Bras A., Rueff J., Farmer P.B., Bailey E. Transplacental exposure to genotoxins. Evaluation in haemoglobin of hydroxyethylvaline adduct levels in smoking and non-smoking mothers and their newborns. Carcinogenesis. 15:1994;1271-1274.
98. Föst U., Hallier E., Ottenwälder H., Bolt H.M., Peter H. Distribution of ethylene oxide in human blood and its implications for biomonitoring. Hum. Exp. Toxicol. 10:1991;25-31.
99. Vollmer D.M., Thier R., Bolt H.M. Determination of the ethylene oxide adduct S-(2-hydroxyethyl)cysteine by a fluorimetric HPLC method in albumin and globin from human blood. Fresenius J. Anal. Chem. 362:1998;324-328.
100. Hallier E., Langhof T., Dannappel D., Leutbecher M., Schröder K., Goergens H.W., Muller A., Bolt H.M. Polymorphism of glutathione conjugation of methyl bromide. Arch. Toxicol. 67:1993;173-178.
101. Yong L.C., Schulte P.A., Wiencke J.K., Boeniger M.F., Connaly L.B., Walker J.T., Whelan E.A., Ward E.M. Hemoglobin adducts and sister chromatid exchanges in hospital workers exposed to ethylene oxide: effects of glutathione S-transferase T1 and M1 genotypes. Cancer Epidemiol. Biomarkers Prev. 10:2001;539-550.
102. Fennell T.R., MacNeela J.P., Morris R.W., Watson M., Thompson C.L., Bell D.A. Hemoglobin adducts from acrylonitrile and ethylene oxide in cigarette smokers: effects of glutathione S-transferase T1-null and M1-null genotypes. Cancer Epidemiol. Biomarkers Prev. 9:2000;705-712.
103. Ehrenberg L., Moustacchi E., Osterman-Golkar S., Ekman G. Dosimetry of genotoxic agents and dose-response relationships of their effects. Mutat. Res. 123:1983;121-182.
104. Agurell E., Cederberg H., Ehrenberg L., Lindahl-Kiessling K., Rannug U., Törnqvist M. Genotoxic effects of ethylene oxide and propylene oxide: a comparative study. Mutat. Res. 250:1991;229-237.
105. Hengstler J.G., Fuchs J., Gebhard S., Oesch F. Glycolaldehyde causes DNA-protein cross-links: a new aspect of ethylene oxide genotoxicity. Mutat. Res. 304:1994;229-234.
106. Bukvic N., Bavaro P., Soleo L., Fanelli M., Stipani I., Elia G., Susca F., Guanti G. Increment of sister chromatid exchange (SCE) frequencies due to epichlorohydrin (ECH) in vitro treatment in human lymphocytes. Teratog. Carcinog. Mutagen. 20:2000;313-320.
107. Kolman A., Bohušová T., Lambert B., Simons J.W.I.M. Induction of 6-thioguanine-resistant mutants in human diploid fibroblasts in vitro with ethylene oxide. Environ. Mol. Mutagen. 19:1992;93-97.
108. Nygren J., Cedervall B., Eriksson S., Dušinská M., Kolman A. Induction of DNA strand breaks by ethylene oxide in human diploid fibroblasts. Environ. Mol. Mutagen. 24:1994;161-167.
109. Kolman A., Spivak I., Näslund M., Dušinská M., Cedervall B. Propylene oxide and epichlorohydrin induce DNA strand breaks in human diploid fibroblasts. Environ. Mol. Mutagen. 30:1997;40-46.
110. Chovanec M., Näslund M., Spivak I., Dušinská M., Cedervall B., Kolman A. Rejoining of DNA strand breaks induced by propylene oxide and epichlorohydrin in human diploid fibroblasts. Environ. Mol. Mutagen. 32:1998;223-228.
111. von der Hude W., Carstensen S., Obe G. Structure-activity relationships of epoxides: induction of sister chromatid exchanges in Chinese hamster V79 cells. Mutat. Res. 249:1991;55-70.
112. Poirier V., Papadopoulo D. Chromosomal aberrations induced by ethylene oxide in a human amniotic cell line in vitro. Mutat. Res. 104:1982;255-260.
113. Zhong B.-Z., Gu Z.-W., Whong W.-Z., Wallace W., Ong T.-M. Comparative study of micronucleus assay and chromosomal aberration analysis in V79 cells exposed to ethylene oxide. Teratog. Carcinog. Mutagen. 11:1992;227-233.
114. Jorritsma U., Cornet M., van Hummelen P., Bolt H.M., Vercruysse A., Kirsch-Volders M., Rogiers V. Comparative mutagenicity of 2-methylpropene (isobutene), its epoxide 2-methyl-1,2-epoxypropane and propylene oxide in the in vitro micronucleus test using human lymphocytes. Mutagenesis. 10:1995;101-104.
115. Bastlová T., Andersson B., Lambert B., Kolman A. Molecular analysis of ethylene oxide-induced mutations at the HPRT locus in human diploid fibroblasts. Mutat. Res. 287:1993;283-292.
116. Kolman A., Chovanec M. Combined effects of γ-radiation and ethylene oxide in human diploid fibroblasts. Mutagenesis. 15:2000;99-104.
117. Lynch D.W., Lewis T.R., Moorman W.J., Burg J.R., Gulati D.K., Kaur P., Sabharwal P.P.S. Sister chromatid exchanges and chromosome aberrations in lymphocytes from monkeys exposed to ethylene oxide and propylene oxide by inhalation. Toxicol. Appl. Pharmacol. 76:1984;85-95.
118. Zhang L.-H., Jenssen D. Studies on intrachromosomal recombination in SP5/V79 Chinese hamster cells upon exposure to different agents related to carcinogenesis. Carcinogenesis. 15:1994;2303-2310.
119. Mlejnek P., Kolman A. Effects of three epoxides - ethylene oxide, propylene oxide and epichlorohydrin - on cell cycle progression and cell death in human diploid fibroblasts. Chem. Biol. Interact. 117:1999;219-239.
120. Kolman A., Näslund M., Osterman-Golkar S., Scalia-Tomba G.-P., Meyer A. Comparative studies of in vitro transformation by ethylene oxide and γ-radiation of C3H/10T1/2 cells. Mutagenesis. 4:1989;58-61.
121. Kolman A., Näslund M., Osterman-Golkar S. Studies of the rad-equivalence of ethylene oxide in the presence and absence of 12-O-tetradecanoylphorbol-13-acetate (TPA) in C3H/10T1/2 cells. Toxicol. Lett. 53:1990;307-313.
122. Kolman A., Dušinská M., Slameòová D. In vitro transformation of C3H/10T1/2 and SHE cells by propylene oxide and epichlorohydrin. Alternatives Lab. Anim. 22:1994;180-184.
123. Kolman A., Dušinská M. Comparison of propylene oxide and epichlorohydrin effects in two transformation tests (C3H/10T1/2 and SHE cells). Toxicol. Lett. 91:1995;213-221.
124. L. Ehrenberg, Purposes and methods of comparing effects of radiation and chemicals, in: Radiological Equivalents of Chemical Pollutants, IAEA, Vienna, 1980, pp. 23-36.
125. van Sittert N.J., Boogaard P.J., Natarajan A.T., Tates A.D., Ehrenberg L.G., Törnqvist M. Formation of DNA adducts and induction of mutagenic effects in rats following 4 weeks inhalation exposure to ethylene oxide as a basis for cancer risk assessment. Mutat. Res. 447:2000;27-48.
126. United Nations Scientific Committee on the Effects of Atomic Radiation (UNSCEAR), UNSCEAR 2000 Report to the General Assembly, with Scientific Annexes: Effects, vol. II, United Nations, New York, 2000, pp. 358-361.
127. US Environmental Protection Agency, Health Assessment Document for Ethylene Oxide, EPA-600/8-84-009F, 1985.
128. US Occupational Safety and Health Administration, Office of Carcinogen Standards, Preliminary Quantitative Risk Assessment for Ethylene Oxide, 1983.
129. Waters M.D., Stack H.F., Jackson M.A. Genetic toxicology data in the evaluation potential human environmental carcinogens. Mutat. Res. 437:1999;21-49.